Merz Aesthetics Inc:企業の戦略的SWOT分析

◆英語タイトル:Merz Aesthetics Inc - Strategic SWOT Analysis Review
◆商品コード:SWOT20MY2326
◆発行会社(調査会社):GlobalData
◆発行日:2020年1月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Merz Aesthetics Inc – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Merz Aesthetics Inc (Merz Aesthetics), a subsidiary of the Merz Pharma Group, develops and commercializes solutions in the areas of minimally invasive aesthetics. The company’s product portfolio includes Radiesse volumizing filler, Xeomin (incobotulinumtoxinA), Asclera (polidocanol) injection, and Belotero Balance. Merz Aesthetics offers a variety of treatment options including devices, injectables and skincare, which allow healthcare professionals to employ Merz technologies for the treatment of a various concerns of the patients in the US. The company also distributes other manufacturer’s products including Mederma, a topical gel that reduces scars on the skin; and Aqua Glycolic, an alpha hydroxyl acid-based skin care product that enables to diminish visible signs of aging. Merz Aesthetics is headquartered in Raleigh, North Carolina, the US.

Merz Aesthetics Inc Key Recent Developments

Nov 12,2019: Merz forms fully focused global medical aesthetics business: Merz Aesthetics
Aug 16,2019: Merz announces key governance changes
Jun 05,2018: Merz Venture Initiative Increases Investment in Cytrellis

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
Section 1 – About the Company
Merz Aesthetics Inc – Key Facts
Merz Aesthetics Inc – Key Employees
Merz Aesthetics Inc – Major Products and Services
Merz Aesthetics Inc – History
Merz Aesthetics Inc – Company Statement
Merz Aesthetics Inc – Locations And Subsidiaries
Head Office
Section 2 – Company Analysis
Company Overview
Merz Aesthetics Inc – Business Description
Merz Aesthetics Inc – SWOT Analysis
SWOT Analysis – Overview
Merz Aesthetics Inc – Strengths
Merz Aesthetics Inc – Weaknesses
Merz Aesthetics Inc – Opportunities
Merz Aesthetics Inc – Threats
Merz Aesthetics Inc – Key Competitors
Section 3 – Company’s Recent Developments
Nov 12, 2019: Merz forms fully focused global medical aesthetics business: Merz Aesthetics
Aug 16, 2019: Merz announces key governance changes
Section 4 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Merz Aesthetics Inc, Key Facts
Merz Aesthetics Inc, Key Employees
Merz Aesthetics Inc, Major Products and Services
Merz Aesthetics Inc, History
Merz Aesthetics Inc, Key Competitors

★海外企業調査レポート[Merz Aesthetics Inc:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Grupo Farma:企業の戦略的SWOT分析
    Grupo Farma - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Polpharma SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Polpharma SA (Polpharma) undertakes the research, manufacture and marketing of generic drugs, prescription drugs and over the counter medications. It provides drugs in cardiology, gastroenterology and neurology areas. The company also manufactures over the counter (OTC) medications, dietary …
  • Humana Inc (HUM):製薬・医療:M&Aディール及び事業提携情報
    Summary Humana Inc (Humana) is a health and well-being company that offers health insurance and Medicare plans, insurance products, and health and wellness services to healthcare providers, employers, individuals, administrators, government, and the public sector. The company’s Medicare products and …
  • Qualcomm Incorporated (QCOM):企業の財務・戦略的SWOT分析
    Qualcomm Incorporated (QCOM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • OTK GROUP, a.s.:企業の戦略・SWOT・財務情報
    OTK GROUP, a.s. - Strategy, SWOT and Corporate Finance Report Summary OTK GROUP, a.s. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Arabian Bemco Contracting Co. Ltd.:企業の戦略・SWOT・財務分析
    Arabian Bemco Contracting Co. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Arabian Bemco Contracting Co. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Atlantic Pro-Nutrients Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Atlantic Pro-Nutrients Inc (APN) is a health science company that manufactures dietary supplements and functional foods. The company offers products in the areas of women's health, men's health, sports nutrition, immune health, cytokine balance support, adrenal support, antioxidants, bone he …
  • Tokyo Electron Limited:企業の戦略・SWOT・財務情報
    Tokyo Electron Limited - Strategy, SWOT and Corporate Finance Report Summary Tokyo Electron Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • J D Wetherspoon plc:企業の戦略・SWOT・財務分析
    J D Wetherspoon plc - Strategy, SWOT and Corporate Finance Report Summary J D Wetherspoon plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Fujitsu Australia Ltd:企業の戦略的SWOT分析
    Fujitsu Australia Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Albemarle Corporation:企業の戦略・SWOT・財務分析
    Albemarle Corporation - Strategy, SWOT and Corporate Finance Report Summary Albemarle Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Hub International Limited:企業のM&A・事業提携・投資動向
    Hub International Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Hub International Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Ubisoft Entertainment S.A.:企業の戦略・SWOT・財務情報
    Ubisoft Entertainment S.A. - Strategy, SWOT and Corporate Finance Report Summary Ubisoft Entertainment S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Guangzhou Boji Medical & Biotechnological Co Ltd (300404):製薬・医療:M&Aディール及び事業提携情報
    Summary Guangzhou Boji Medical & Biotechnological Co Ltd (BOJI) is a contract research organization. The organization provides services including regulatory affairs, preclinical research, clinical trials I-IV, PMS, clinical trial for medical devices, post marketing studies (PMS), data management and …
  • Ignyta Inc (RXDX)-製薬・医療分野:企業M&A・提携分析
    Summary Ignyta Inc (Ignyta), formerly NexDx Inc is a drug manufacturing company that discovers, develops and commercializes new drugs targeting activated genes in cancer cells for the treatment of cancer patients. The company develops products using integrated therapeutic (Rx) and companion diagnost …
  • UnitedHealth Group Inc (UNH):企業の財務・戦略的SWOT分析
    UnitedHealth Group Inc (UNH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Waterloo Industries Inc:企業の戦略的SWOT分析
    Waterloo Industries Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Avangrid Inc (AGR):企業の財務・戦略的SWOT分析
    Avangrid Inc (AGR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • PellePharm Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary PellePharm Inc (PellePharm), a subsidiary of BridgeBio Inc, is a biotechnology company that develops and commercializes treatments for rare genetic dermatological conditions. The company’s lead clinical program, Patidegib, is a first-in-class topical gel formulation of a proprietary hedgehog …
  • Anadarko Petroleum Corp (APC):石油・ガス:M&Aディール及び事業提携情報
    Summary Anadarko Petroleum Corp (Anadarko) is an independent upstream oil and gas company, which carries out exploration, development, production, and marketing of natural gas, crude oil, condensate, and natural gas liquids (NGLs) from its assets. It also involves in gathering, processing, treating, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆